Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 967
TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300932(US10131658, Compound 203)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300949(US10131658, Compound 215)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300939(US10131658, Compound 198 | BDBM300948)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300946(US10131658, Compound 213)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199411(CHEMBL3951678 | US10131658, Compound 87)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199345(CHEMBL3893700 | US10131658, Compound 201)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199195(CHEMBL3892042 | US10131658, Compound 8)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300918(US10131658, Compound 5)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199337(CHEMBL3962660 | US10131658, Compound 6)
Affinity DataIC50: 10nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199333(CHEMBL3942926 | US10131658, Compound 61)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300915(US10131658, Compound 2)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300916(US10131658, Compound 3)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199405(CHEMBL3927311 | US10131658, Compound 214)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300917(US10131658, Compound 4)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199399(CHEMBL3909977 | US10131658, Compound 212)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199398(CHEMBL3952235 | US10131658, Compound 211)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199398(CHEMBL3952235 | US10131658, Compound 211)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199411(CHEMBL3951678 | US10131658, Compound 87)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300941(US10131658, Compound 209)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300940(US10131658, Compound 208)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300939(US10131658, Compound 198 | BDBM300948)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300938(US10131658, Compound 207)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300937(US10131658, Compound 206)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300935(US10131658, Compound 93)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199410(CHEMBL3933968 | US10131658, Compound 205)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199401(CHEMBL3970391 | US10131658, Compound 204)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199407(CHEMBL3902668 | US10131658, Compound 202)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199400(CHEMBL3899210 | US10131658, Compound 200)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300928(US10131658, Compound 63)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300927(US10131658, Compound 197)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300926(US10131658, Compound 196)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199197(CHEMBL3923968 | US10131658, Compound 11)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM50199339(CHEMBL3914945 | US10131658, Compound 60)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300923(US10131658, Compound 10)
Affinity DataIC50: 505nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300920(US10131658, Compound 7)
Affinity DataIC50: 5.50E+3nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300914(US10131658, Compound 1)
Affinity DataIC50: 5.50E+3nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-5/beta-1 [T112H](Human)
The Regents of The University of California

US Patent
LigandPNGBDBM300922(US10131658, Compound 9)
Affinity DataIC50: 5.50E+3nMAssay Description:A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...More data for this Ligand-Target Pair
In DepthDetails
US Patent